The MTMR4 (Myotubularin-Related Protein 4) antibody is a tool used to study the MTMR4 protein, a member of the myotubularin family of lipid phosphatases. MTMR4 specifically dephosphorylates phosphatidylinositol 3-phosphate (PI3P) and phosphatidylinositol 3.5-bisphosphate [PI(3.5)P2], phosphoinositide lipids that regulate membrane trafficking, autophagy, and cellular signaling. Unlike other myotubularin-related proteins, MTMR4 lacks a functional phosphatase domain and instead forms heterodimers with catalytically active family members (e.g., MTMR1/2) to modulate their enzymatic activity or substrate specificity.
MTMR4 is implicated in diverse cellular processes, including endosomal sorting, receptor degradation, and cytoskeletal organization. Dysregulation of MTMR4 has been linked to cancer progression, neurodevelopmental disorders, and muscular pathologies, though its exact role remains under investigation. The MTMR4 antibody enables researchers to detect and quantify MTMR4 expression in tissues or cell lines via techniques like Western blotting, immunofluorescence, or immunohistochemistry. It is also used to explore MTMR4’s interactions with signaling partners and its subcellular localization, particularly in endosomal compartments.
Current research focuses on clarifying MTMR4’s regulatory mechanisms in phosphoinositide metabolism and its potential as a therapeutic target. The antibody’s specificity and reliability are critical for dissecting MTMR4’s contributions to disease pathways and cellular homeostasis.